Zimmer Biomet Holdings (ZBH) Other Non-Current Liabilities (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted Other Non-Current Liabilities of $638.7 million for Q2 2026, up 1.27% on a QoQ basis from $630.7 million in Q1 2026, and down 27.32% year-over-year from $878.8 million in Q2 2025.
Analysis
Zimmer Biomet Holdings (ZBH) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings has reported Other Non-Current Liabilities for 18 years, with the latest figure at $638.7 million in Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 27.32% year-over-year to $638.7 million in Q2 2026; TTM through Jun 2026 was $638.7 million, a 27.32% decrease from a year earlier, with the FY2025 full-year figure at $626.1 million, down 15.86% from the prior year.
- Other Non-Current Liabilities was $638.7 million for Q2 2026 at Zimmer Biomet Holdings, up from $630.7 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $1.2 billion in Q2 2024, with the low at $577.0 million in Q1 2024.
- Average Other Non-Current Liabilities over 5 years is $739.3 million, with a median of $638.0 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2026: Other Non-Current Liabilities jumped 87.76% in 2024, then sank 30.61% in 2026.
- Over 5 years, Other Non-Current Liabilities stood at $632.6 million in 2022, then surged by 46.35% to $925.8 million in 2023, then decreased by 19.63% to $744.1 million in 2024, then decreased by 15.86% to $626.1 million in 2025, then grew by 2.01% to $638.7 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $638.7 million (Q2 2026), $630.7 million (Q1 2026), and $626.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 638.70 Mn |
| Mar 31, 2026 | 630.70 Mn |
| Dec 31, 2025 | 626.10 Mn |
| Sep 30, 2025 | 806.40 Mn |
| Jun 30, 2025 | 878.80 Mn |
| Mar 31, 2025 | 908.90 Mn |
| Dec 31, 2024 | 744.10 Mn |
| Sep 30, 2024 | 1.03 Bn |
| Jun 30, 2024 | 1.21 Bn |
| Mar 31, 2024 | 577.00 Mn |
| Dec 31, 2023 | 925.80 Mn |
| Sep 30, 2023 | 631.90 Mn |
| Jun 30, 2023 | 642.00 Mn |
| Mar 31, 2023 | 637.40 Mn |
| Dec 31, 2022 | 632.60 Mn |
| Sep 30, 2022 | 608.70 Mn |
| Jun 30, 2022 | 591.00 Mn |
| Mar 31, 2022 | 593.10 Mn |
| Dec 31, 2021 | 583.00 Mn |
| Sep 30, 2021 | 606.70 Mn |